GMS Ventures & Investments - Mar 11, 2025 SCHEDULE 13D/A Report for Outlook Therapeutics, Inc. Common Stock, par value $0.01 per share (OTLK)

Filing Manager: GMS Ventures & Investments
Reporting Manager: SUKHTIAN GHIATH M.
Security: Outlook Therapeutics, Inc. Common Stock, par value $0.01 per share
Symbol: OTLK
Shares outstanding: 38.9M shares
Disclosed Ownership: 16.2M shares
Ownership: 41.6%
Form type: SCHEDULE 13D/A
Date filed: 3/12/2025, 09:11 PM
Date of event: Mar 11, 2025
Previous filing: Jan 22, 2025
Next filing: May 28, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
GMS VENTURES & INVESTMENTS	41.6%	16.2M	0	16.2M	/s/ Lawrence A. Kenyon	Lawrence A. Kenyon/Attorney-in-Fact	0001804598
SUKHTIAN GHIATH M.	41.6%	16.2M	0	16.2M	/s/ Lawrence A. Kenyon	Lawrence A. Kenyon/Attorney-in-Fact	0001717441